NumerixS Investment Technologies’s AstraZeneca AZN Stock Holding History

NumerixS Investment Technologies’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,650	Closed	-$280K	–	89
2020 Q2	$280K	Sell	2,650 -398	-13%	-$41.1K	0.08%	295
2020 Q1	$272K	Buy	+3,048	New	+$287K	0.14%	171
2019 Q3	–	Sell	-4,100	Closed	-$338K	–	1011
2019 Q2	$338K	Buy	4,100 +1,700	+71%	+$133K	0.1%	262
2019 Q1	$206K	Sell	2,400 -3,950	-62%	-$311K	0.03%	655
2018 Q4	$480K	Buy	+6,350	New	+$496K	0.16%	144
2018 Q3	–	Sell	-10,900	Closed	-$761K	–	1190
2018 Q2	$761K	Buy	+10,900	New	+$784K	0.17%	163
2017 Q3	–	Sell	-11,200	Closed	-$764K	–	1150
2017 Q2	$764K	Buy	+11,200	New	+$731K	0.11%	225
2017 Q1	–	Sell	-2,104	Closed	-$115K	–	1158
2016 Q4	$115K	Buy	+2,104	New	+$119K	0.01%	824
2015 Q2	–	Sell	-8,200	Closed	-$561K	–	626
2015 Q1	$561K	Buy	+8,200	New	+$570K	0.1%	277

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

NumerixS Investment Technologies's AZN Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of AstraZeneca (AZN) in Q3 2020, closing a stake of 2,650 shares — an estimated $280K sold.

NumerixS Investment Technologies first reported a position in AZN in Q1 2015 and held it in 9 quarters. The position peaked at $764K in Q2 2017. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

NumerixS Investment Technologies reported no remaining AstraZeneca position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 2,650 AstraZeneca shares in Q3 2020, an estimated $280K.
NumerixS Investment Technologies first reported a position in AstraZeneca in Q1 2015 and held it in 9 quarters.
NumerixS Investment Technologies's AstraZeneca position peaked at $764K in Q2 2017.
723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.